These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 212279)

  • 41. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.
    Pfeifer MA; Ward K; Malpass T; Stratton J; Halter J; Evans M; Beiter H; Harker LA; Porte D
    J Clin Invest; 1984 Sep; 74(3):1063-72. PubMed ID: 6088579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characteristics of beta-adrenergic-agonist binding to rat adipocyte membranes. Evidence that (+/-)-[3H]hydroxybenzylisoproterenol interacts selectively with the adipocyte beta-adrenergic receptors.
    Giudicelli Y; Lacasa D; Agli B
    Biochim Biophys Acta; 1982 Mar; 715(1):105-15. PubMed ID: 6122470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Relative affinities of S 3341 and clonidine for the alpha 2- and alpha 2-adrenoceptors of the rat brain (author's transl)].
    Guicheney P; Dausse JP; Meyer P
    J Pharmacol; 1981; 12(3):255-62. PubMed ID: 6116834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Altered adrenergic response and specificity of the receptors in rat ascites hepatoma AH130.
    Sanae F; Miyamoto K; Koshiura R
    Cancer Res; 1989 Nov; 49(22):6242-6. PubMed ID: 2553251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective labeling of alpha-noradrenergic receptors in rat brain with [3H]dihydroergokryptine.
    Greenberg DA; Snyder SH
    Life Sci; 1977 Mar; 20(6):927-31. PubMed ID: 191710
    [No Abstract]   [Full Text] [Related]  

  • 47. Subtype-selective down-regulation of rat renal cortical alpha- and beta-adrenergic receptors by catecholamines.
    Snavely MD; Ziegler MG; Insel PA
    Endocrinology; 1985 Nov; 117(5):2182-9. PubMed ID: 2995007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of alpha-adrenergic receptor subtypes in the rat renal cortex. Differential regulation of alpha 1- and alpha 2-adrenergic receptors by guanyl nucleotides and Na.
    Snavely MD; Insel PA
    Mol Pharmacol; 1982 Nov; 22(3):532-46. PubMed ID: 6296651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adrenergic receptor and catecholamine distribution in rat cerebral cortex: binding studies with [3H]prazosin, [3H]idazoxan and [3H]dihydroalprenolol.
    Diop L; Brière R; Grondin L; Reader TA
    Brain Res; 1987 Feb; 402(2):403-8. PubMed ID: 3828804
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors.
    Convents A; De Backer JP; Convents D; Vauquelin G
    Mol Pharmacol; 1987 Jul; 32(1):65-72. PubMed ID: 2885739
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electroconvulsive shock and reserpine increase alpha 1-adrenoceptor binding sites but not norepinephrine-stimulated phosphoinositide hydrolysis in rat brain.
    Blendy JA; Stockmeier CA; Kellar KJ
    Eur J Pharmacol; 1988 Nov; 156(2):267-70. PubMed ID: 2853676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of the human platelet alpha-adrenergic receptor. Correlation of [3H]dihydroergocryptine binding with aggregation and adenylate cyclase inhibition.
    Alexander RW; Cooper B; Handin RI
    J Clin Invest; 1978 May; 61(5):1136-44. PubMed ID: 207726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reserpine and sympathetic denervation cause an increase of postsynaptic alpha 2-adrenoceptors.
    Watanabe Y; Lai RT; Maeda H; Yoshida H
    Eur J Pharmacol; 1982 May; 80(1):105-8. PubMed ID: 6284526
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
    Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
    Asano M; Hashimoto H; Nakashima M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological evidence for alpha-2 adrenoceptor heterogeneity: differential binding properties of [3H]rauwolscine and [3H]idazoxan in rat brain.
    Boyajian CL; Leslie FM
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1092-8. PubMed ID: 2885406
    [TBL] [Abstract][Full Text] [Related]  

  • 57. (alpha S)-erythro-alpha-methylepinephrine: preparation and stereoselective binding to adrenergic receptors in rat forebrain.
    Taylor CA; Smith HE; Goldberg MR; Robertson D
    J Med Chem; 1981 Oct; 24(10):1261-3. PubMed ID: 7328589
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
    Michel MC; Brodde OE; Schnepel B; Behrendt J; Tschada R; Motulsky HJ; Insel PA
    Mol Pharmacol; 1989 Mar; 35(3):324-30. PubMed ID: 2564631
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanisms underlying the differential sensitivity to alpha 1-adrenoceptor activation in the bisected rat vas deferens.
    Sallés J; Badia A
    Br J Pharmacol; 1991 Feb; 102(2):439-45. PubMed ID: 1673073
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of trypsin on binding of [3H]epinephrine and [3H]-dihydroergocryptine to rat liver plasma membranes. Evidence for interconversion of binding sites.
    El-Refai MF; Exton JH
    J Biol Chem; 1980 Jun; 255(12):5853-8. PubMed ID: 6247349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.